본문 바로가기

Changing trends in the incidence and spectrum of cancers between 1990 and 2021 among HIV-infected patients in Busan, Korea

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
JOURNAL OF INFECTION AND CHEMOTHERAPY29(6) · pp.571 · 2023
피인용
Web of Science 6Scopus 5
FWCI (Scopus)
0.56
JCR IF
JCR 2022 2.2
ISSN
1341-321X

저자

  1. 이순옥제1저자Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
  2. 이정은Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
  3. 심용기Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
  4. 이신원Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
  5. 고우석Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
  6. 김진미Pusan Natl Univ Hosp, Biomed Inst, Dept Stat, Pusan, South Korea
  7. 강진숙Inje Univ, Dept Internal Med, Div Infect Dis, Coll Med, Pusan, South Korea
  8. Son, HyunjinDong A Univ, Donga Univ Hosp, Dept Prevent Med, Sch Med, Pusan, South Korea
  9. 이선희교신저자Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea

초록

Background: Long-term follow-up data on cancer incidence and spectrum among human immunodeficiency virus (HIV)-infected individuals in Korea have been scarce. Material and Methods: This retrospective cohort study included HIV-infected individuals visiting a tertiary care hospital in Busan, South Korea between 1990 and 2021. The observation was divided into 4 periods. The incidence rate was calculated using direct standardization on age and sex, stratified by calendar period. Results: Of the 1,297 patients, 92 patients (7.1%) were diagnosed with 97 cancers. Excluding 37 patients with prevalent cancer, 1,260 patients were followed for a total of 8,803.7 person-years (PYs), and 55 patients developed 60 incident cancers including 5 second primary incident cancers. In men, the AIDS-defining cancer (ADC) incidence decreased from 294.7 per 100,000 PYs in 1990–1997 to 124.8 per 100,000 PYs in 2014–2021, while the non-AIDS-defining cancer (NADC) incidence increased from 0 per 100,000 PYs to 316.5 per 100,000 PYs during the same period. The proportion of virus-unrelated NADCs (VU-NADCs) increased from 33.3% in 1998–2005 to 49% in 2014–2021. The proportion of human papillomavirus-associated cancers (HPVACs) has recently increased in both ADCs and NADCs. The median time from HIV diagnosis to their first cancer was 1.48 years for ADCs, 6.11 years for VR-NADCs, 8.3 years for VU-NADCs, and 11.5 years for HPVACs. Conclusion: The incidence of NADCs is increasing with the aging of HIV-infected patients, and thus, it is necessary to promote cancer screening and prevention programs.

키워드

CancerEpidemiologyHIVHUMAN-IMMUNODEFICIENCY-VIRUSAIDS-DEFINING CANCERSPOPULATIONRISKERA

식별자

Scopus EID
2-s2.0-85150338462
WoS UID
001054050200001